Butterfly Network, Inc. (BFLY)
NYSE: BFLY · IEX Real-Time Price · USD
0.822
+0.002 (0.28%)
Apr 19, 2024, 9:42 AM EDT - Market open
Butterfly Network Market Cap
Butterfly Network has a market cap or net worth of $172.23 million as of April 19, 2024. Its market cap has decreased by -69.87% in one year.
Market Cap
172.23M
Enterprise Value
59.07M
1-Year Change
-69.87%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since May 21, 2020, Butterfly Network's market cap has decreased from $375.00M to $172.23M, a decrease of -54.07%. That is a compound annual growth rate of -18.05%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 170.50M | -8.97% |
Apr 16, 2024 | 187.30M | -3.95% |
Apr 15, 2024 | 195.00M | 5.41% |
Apr 12, 2024 | 185.00M | -6.04% |
Apr 11, 2024 | 196.90M | -1.94% |
Apr 10, 2024 | 200.80M | -5.42% |
Apr 9, 2024 | 212.30M | 1.00% |
Apr 8, 2024 | 210.20M | -0.99% |
Apr 5, 2024 | 212.30M | 2.21% |
Apr 4, 2024 | 207.70M | -4.06% |
Apr 3, 2024 | 216.50M | 3.00% |
Apr 2, 2024 | 210.20M | -2.91% |
Apr 1, 2024 | 216.50M | -3.69% |
Mar 28, 2024 | 224.80M | 1.90% |
Mar 27, 2024 | 220.60M | 6.01% |
Mar 26, 2024 | 208.10M | -3.88% |
Mar 25, 2024 | 216.50M | 1.98% |
Mar 22, 2024 | 212.30M | -3.76% |
Mar 21, 2024 | 220.60M | -6.21% |
Mar 20, 2024 | 235.20M | 4.63% |
Mar 19, 2024 | 224.80M | - |
Mar 18, 2024 | 224.80M | 0.94% |
Mar 15, 2024 | 222.70M | - |
Mar 14, 2024 | 222.70M | -1.85% |
Mar 13, 2024 | 226.90M | 4.80% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Alpha Tau Medical | 190.48M |
Outlook Therapeutics | 188.86M |
23andMe Holding Co. | 188.39M |
Inventiva | 187.87M |
Alimera Sciences | 187.43M |
Capricor Therapeutics | 186.81M |
Greenwich LifeSciences | 185.27M |
Gossamer Bio | 185.16M |